Canadian Task Force on Preventive Health Care

Selected References

Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients

  1. Canadian Task Force on the Periodic Health Examination: The periodic health examination. CMAJ 1979; 121: 1193-1254
  2. Riordan-Eva P: Blindness. In Vaughan D, Asbury T, Tabbara KF (eds): General Ophthalmology, 12th ed, Appleton and Lange, Norwalk, Conn, 1989: 384-388
  3. The Prevention of Blindness (no 518, Technical Report series), World Health Organization, Geneva, 1973
  4. Nelson KA: Visual impairment among elderly Americans: statistics in transition. J Vis Impair Blind 1987; 81: 331-334
  5. Sommer A, Tielsch JM, Katz J et al: Racial differences in the cause-specific prevalence of blindess in East Baltimore. N Engl J Med 1991; 325: 1412-1417
  6. Statistical Information on the Client Population of the CNIB, Canadian National Institute for the Blind, Toronto, 1989
  7. McMurdo MET, Baines PS: The detection of visual disability in the elderly. Health Bull 1988; 46: 327-329
  8. Stults BM: Preventive health care for the elderly. West J Med 1984; 141: 832-845
  9. Stone DH, Shannon DJ: Screening for impaired visual acuity in middle age in general practice. BMJ 1978; 2: 859-863
  10. Hiller R, Krueger DE: Validity of a survey question as a measure of visual acuity impairment. Am J Public Health 1983; 73: 93-96
  11. Ederer F, Krueger DE, Mowery RL et al: Lessons from the Visual Acuity Impairment Survey Pilot Study. Am J Public Health 1986; 76: 160-165
  12. Lowenstein JI, Palmberg PF, Connett JE et al: Effectiveness of a pinhole method for visual screening. Arch Ophthalmol 1985; 103: 222-223
  13. Long CA, Holden R, Mulkerrin E et al: Opportunistic screening of visual acuity of elderly patients attending outpatient clinics. Age Ageing 1991; 20: 392-395
  14. Strahlman E, Ford D, Whelton P et al: Vision screening in a primary care setting. A missed opportunity? Arch Intern Med 1990; 150: 2159-2164
  15. Tielsch JM, Sommer A, Witt K et al: Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol 1990; 108: 286-290
  16. Podger MJ, Leske MC, Ederer F: Incidence estimates for lens changes, macular changes, open angle glaucoma and diabetic retinopathy. Am J Epidemiol 1983; 118: 206-212
  17. McGuinness R: The Framingham Eye Study. Am J Ophthalmol 1978; 86: 852-853
  18. Kahn HA, Moorhead HB: Statistics on Blindness in the Model Reporting Area, 1969-1970 (PHS publ no [NIH] 73-427), US Department of Health, Education, and Welfare, Washington, 1973
  19. Johasson F, Thordarson K: Prevalence of ocular disease and blindness in a rural area in the Eastern Region of Iceland during 1980 through 1984. Acta Ophthalmol 1987; 65 (suppl 182): 40-43
  20. Leske MC, Sperduto RD: The epidemiology of senile cataracts: a review. [review] Am J Epidemiol 1983; 118: 152-165
  21. Straatsma BR, Meyer KT, Bastek JV et al: Posterior chamber intraocular lens implantation by ophthalmology residents. Opthalmology 1983; 90: 327-335
  22. Miller ST, Graney MJ, Elam JT et al: Predictions of outcomes from cataract surgery in elderly persons. Ophthalmology 1988; 95: 1125-1129
  23. Bernth-Petersen B: Outcome of cataract surgery I. Acta Ophthalmol 1982; 60: 235-242
  24. Immonen I, Tuominen R, Raivio I: Visual results and social rehabilitation after cataract surgery. Acta Ophthalmol 1988; 66: 572-576
  25. Applegate WB, Miller ST, Elam JT et al: Impact of cataract surgery with lens implantation on vision and physical function in elderly patients. JAMA 1987; 257: 1064-1066
  26. Carlson AN, Tetz MR, Apple D: Infectious complications of modern cataract surgery and intraocular lens implantation. Infect Dis Clin North Am 1989; 3: 339-355
  27. Lorusso V, Moramarco A, Pacella E et al: Intraocular lens complications. Ann Ophthalmol 1990; 22: 377-381
  28. Ferris FL: Senile macular degeneration: review of epidemiological features. Am J Epidemiol 1983; 118: 132-151
  29. Sperduto RD, Seigel D: Senile lens and senile macular changes in a population-based sample. Am J Ophthalmol 1980; 90: 86-91
  30. Hyman LG, Lilienfeld AM, Ferris FL et al: Senile macular degeneration: a case-control study. Am J Epidemiol 1983; 118: 213-227
  31. Smiddy WE, Fine SL: Prognosis of patients with bilateral macular drusen. Ophthalmology 1984; 91: 271-277
  32. Gregor Z, Bird AC, Chisholm IH: Senile disciform macular degeneration in the second eye. Br J Ophthalmol 1977; 61: 141-147
  33. Bressler SB, Bressler NM, Fine SL et al: Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol 1982; 93: 157-163
  34. Fine AM, Elman MJ, Ebert JE et al: Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 1986; 104: 513-514
  35. Fine SL: Early detection of extra foveal neurovascular membranes by daily central field evaluation. Ophthalmology 1985; 92: 603-609
  36. Yannuzzi LA: A modified Amsler grid. Ophthalmology 1982; 89: 157-159
  37. Macular Photocoagulation Study Group: Argon laser photocoagulation for senile macular degeneration. Arch Ophthalmol 1982; 100: 912-918
  38. Moorfields Macular Study Group: Retinal pigment epithelial detachments in the elderly: a controlled trial of argon laser photocoagulation. Br J Ophthalmol 1982; 66: 1-16
  39. Moorfields Macular Study Group: Treatment of senile disciform macular degeneration: a single blind randomised trial by argon laser photocoagulation. Br J Ophthalmol 1982; 66: 745-753
  40. Coscas G, Soubrane G: Photocoagulation de néovaisseaux sou-rétiniens par le laser à argon dans la dégénérescence maculaire sénile. Bull Mem Soc Fr Ophtalmol 1982; 83: 102-105
  41. Grey RHB, Bird AC, Chisholm IH: Senile disciform macular degeneration: features indicating suitability for photocoagulation. Br J Ophthalmol 1979; 63: 85-89
  42. Macular Photocoagulation Group: Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991; 109: 1220-1231
  43. Canadian Ophthalmology Study Group: Argon green vs. krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. Arch Ophthalmol 1993; 111: 181-185
  44. Hollows FC, Graham PA: Intraocular pressure, glaucoma and glaucoma suspects in a defined population. Br J Ophthalmol 1966; 50: 570-586
  45. Bengtsson B: The prevalence of glaucoma. Br J Ophthalmol 1981; 65: 46-49
  46. Leibowitz HM, Krueger DE, Maunder LR et al: The Framingham Eye Study Monograph. Surv Ophthalmol 1980; 24 (suppl): 366-610
  47. Stromberg U: Ocular hypertension. Acta Ophthalmol 1962; 69 (suppl): 7-75
  48. Bankes JLK, Perkins ES, Tsolakis S et al: Bedford glaucoma survey. BMJ 1968; 1: 791-796
  49. Armaly MF: On the distribution of applanation pressure and arcuate scotoma. In Paterson G, Miller SJH, Paterson GD (eds): Drug Mechanisms in Glaucoma, Little, Brown and Company, Boston, 1966: 167-189
  50. Klein BEK, Klein R, Sponsel WE et al: Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 1499-1504
  51. Armaly MF, Krueger DE, Maunder L et al: Biostatistical analysis of the Collaborative Glaucoma Study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol 1980; 98: 2163-2171
  52. O'Brien C, Schwartz B, Takamoto T: Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 1991; 111: 491-500
  53. Leske MC: The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983; 118: 166-191
  54. Ford VJ, Zimmerman TJ, Kooner A: A comparison of screening methods for the detection of glaucoma. [abstract] Invest Ophthalmol Vis Sci 1982; 22 (suppl): 257
  55. Epstein DL (ed): Examination of the eye in glaucoma. In Chandler & Grant's Glaucoma, 3rd ed, Lea & Febiger, Philadelphia, 1986: 74-90
  56. Schwartz JT: Methodologic differences and measurement of cup-disc ratio: an epidemiologic assessment. Arch Ophthalmol 1976; 94: 1101-1105
  57. Holmin C: Optic disc evaluation versus the visual field in chronic glaucoma. Acta Ophthalmol 1982: 275-283
  58. Wood GM, Bosanquet R: Limitations of direct ophthalmoscopy in screening for glaucoma. BMJ 1987; 294: 1587-1588
  59. Bengtsson B: Repeated visual field screening in the aged. Acta Ophthalmol 1988; 66: 659-661
  60. Trope GE, Britton R: A comparison of Goldmann and Humphrey automated perimetry in patients with glaucoma. Br J Ophthalmol 1987; 71: 489-493
  61. Messmer C, Flammer J, Stumpfig D: Influence of betaxolol and timolol on the visual fields of patients with glaucoma. Am J Ophthalmol 1991; 112: 678-681
  62. Becker B, Morton WR: Topical epinephrine in glaucoma suspects. Am J Ophthalmol 1966; 62: 272-277
  63. Levene RZ: Uniocular miotic therapy. Trans Am Acad Ophthalmol Otolaryngol 1975; 79: 376-380
  64. Shin DH, Kolker AR, Kass MA et al: Long-term epinephrine therapy of ocular hypertension. Arch Ophthalmol 1976; 94: 2059-2060
  65. Kitazawa Y: Prophylactic therapy of ocular hypertension: a prospective study. Trans Ophthalmol Soc NZ 1981; 33: 30-32
  66. Epstein DL, Krug JH, Hertzmark E: A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology 1989; 96: 1460-1467
  67. Kass MA, Gordon MO, Hoff MR et al: Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. Arch Ophthalmol 1989; 107: 1590-1598
  68. Kass MA: Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year randomised, double-masked clinical trial. Trans Am Ophthalmol Soc 1989; 87: 598-618
  69. Schulzer M, Drance SM, Douglas GR: A comparison of treated and untreated glaucoma suspects. Ophthalmology 1991; 98: 301-307
  70. Rossetti L, Marchetti I, Orzalesi N et al: Randomized clinical trials on medical treatment of glaucoma: Are they appropriate to guide clinical practice? Arch Ophthalmol 1993; 111: 96-103
  71. Mosteller MW, Zimmerman TJ: The medical management of glaucoma. In Spoor TC (ed): Modern Management of Ocular Diseases, Slack Inc, Thorofare, NJ, 1985: 179-188
  72. Miller SJH (ed): Glaucoma. In Parson's Diseases of the Eye, 18th ed, Churchill Livingstone, Edinburgh, 1990: 226
  73. Glaucoma Laser Trial Research Group: The Glaucoma Laser Trial. Ophthalmology 1990; 97: 1403-1413
  74. Klein R, Klein BEK, Moss SE: Visual impairment in diabetes. Ophthalmology 1984; 91: 1-9
  75. Moss SE, Klein R, Klein BEK: The incidence of vision loss in a diabetic population. Ophthalmology 1988; 95: 1340-1348
  76. Klein R, Moss SE, Klein BE et al: The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989; 96: 1501-1510
  77. Sussman EJ, Tsiaras WG, Soper KA: Diagnosis of diabetic eye disease. JAMA 1982; 247: 3231-3234
  78. Kleinstein RN, Roseman JM, Herman WH et al: Detection of diabetic retinopathy by optometrists. J Am Optom Assoc 1987; 58: 879-882
  79. Moss SE, Klein R, Kessler SD et al: Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 1985; 92: 62-67
  80. Singer DE, Nathan DM, Fogel HA et al: Screening for diabetic retinopathy. Ann Intern Med 1992; 116: 660-671
  81. Forrest RD, Jackson CA, Yudkin JS: Screening for diabetic retinopathy -- comparison of a nurse and a doctor with retinal photography. Diabetes Res 1987; 5: 39-42
  82. Williams R, Nussey S, Humphry R et al: Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. BMJ 1986; 293: 1140-1142
  83. Barrie T, MacCuish AC: Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. [letter] BMJ 1986; 293: 1304-1305
  84. KROC Collaborative Study Group: Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the KROC Collaborative Study. JAMA 1988; 260: 37-41
  85. Diabetic Retinopathy Study Research Group: Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976; 81: 383-396
  86. Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy. Ophthalmology 1981; 88: 583-600
  87. British Multicentre Study Group: Proliferative diabetic retinopathy: treatment with xenon arc photocoagulation. Interim report of multicentre randomized controlled clinical trial. BMJ 1977; 1: 739-742
  88. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. ETDRS report no. 1. Arch Ophthalmol 1985; 103: 1796-1806
  89. British Multicentre Study Group: Photocoagulation for diabetic maculopathy. A randomized controlled trial using the xenon arc. Diabetes 1983; 32: 1010-1016
  90. DAMAD Study Group: Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. Diabetes 1989; 38: 491-498
  91. Early treatment diabetic retinopathy study research group: effects of aspirin treatment on diabetic retinopathy. Ophthalmology 1991; 98: 757-765
  92. Sorbinil Retinopathy Trial Research Group: A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch Opthalmol 1990; 108: 1234-1244
  93. Javitt JC, Canner JK, Sommer A: Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989; 96: 255-264
  94. Javitt JC, Canner JK, Frank RG et al: Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model. Ophthalmology 1990; 97: 483-495
  95. Dasbach EJ, Fryback DG, Newcomb PA et al: Cost effectiveness strategies for detecting diabetic retinopathy. Med Care 1991; 29: 20-39
  96. American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology: Screening guidelines for diabetic retinopathy. Ann Intern Med 1992; 116: 683-685
  97. Cooper RL, Grose GC, Constable IJ: Mass screening of the optic disc for glaucoma: a follow up study. Aust N Z J Ophthalmol 1986; 14: 35-39
  98. Harrison RJ, Wild JM, Hobley AJ: Referral patterns to an ophthalmic out patient clinic by general practitioners and ophthalmic opticians and the role of these professionals in screening for ocular disease. BMJ 1988; 297: 1162-1167
  99. US Preventive Services Task Force: Guide to Clinical Preventive Services: an Assessment of the Effectiveness of 169 Interventions, Williams & Wilkins, Baltimore, 1989: 187-190
  100. Gottlieb LK, Schwartz B, Pauker SG: Glaucoma screening. A cost effectiveness analysis. Surv Ophthalmol 1983; 28: 206-226
  101. Sommer A, Beauchamp GR, Garcia GE et al: Comprehensive Adult Eye Evaluation. Preferred Practice Pattern, American Academy of Ophthalmology, San Francisco, 1989
  102. Battista RN, Huston P, Davis MW: Screening for primary open-angle glaucoma. In Goldbloom RB, Lawrence RS (eds): Preventing Disease: Beyond the Rhetoric, Springer-Verlag, New York, 1990

Link to Full Text of this review

Link to Structured Abstract of this review

Link to Summary Table of Recommendations of this review

Link to 1994 chapter: Screening for visual impairment in the elderly

Top of Page

Home PageCTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
Original Copyright © 1999 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified: November 1, 1999.